The November 25, 2015 “Case Connections” looks at four JBJS Case Connector cases involving injuries to the cervical spine in which the outcomes were about as
Month: November 2015
The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval follows FDA analysis of two
The connection between patient pain and clinical orthopaedic outcomes has received much attention lately. Here are relevant findings from two recent studies: –An in-press study
When treating shoulders with a Bankart lesion that includes an osseous fragment, many orthopaedic surgeons excise the fragment while repairing the capsulolabral complex, and then
The final rule from the Centers for Medicare & Medicaid Services (CMS) regulating “episode-of-care” Medicare payments to hospitals for hip and knee replacements includes a
JBJS Editor’s Choice: Local Antibiotic Delivery for Open Fractures—Ready for an RCT?
In the November 18, 2015 edition of JBJS, Lawing et al. present a well-documented cohort study comparing the outcomes of open-fracture management with local administration
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature during the previous year in 13 subspecialties.
A recent case-control study in Foot & Ankle International found that high-risk diabetic patients (mean age of 60) undergoing reconstructive foot and/or ankle surgery were
On Monday, Nov. 23, 2015 at 8:00 PM EDT, JBJS will host a one-hour webinar focused on managing pediatric supracondylar humeral fractures. Because supracondylar humeral
In the November 4, 2015 Level I JBJS study by Kukkonen et al., patients over the age of 55 were randomized to one of three